KKR & Co. Inc. (KKR) is held by 10 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 3 funds opening new positions, 2 funds adding, and 5 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $1.1M sold). Latest close $93.68 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Sep 3, 2026 · Congress to Nov 16, 2026.
Akre Capital Management · ValueAct Capital · Torray Investment Partners LLC — 10 tracked funds hold KKR. See all holders.
Insiders bought on the open market (0 purchases, $0) vs 1 sale ($1.1M). Insider trading
Carlyle Group Inc. (CG) · AFFILIATED MANAGERS GROUP, INC. (AMG) · Blackstone Inc. (BX) · ROPER TECHNOLOGIES INC (ROP) · Arthur J. Gallagher & Co. (AJG) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Akre Capital Management | 8.93% | 4,981,486 | TRIMMED (-25.8%) Q3 filed Nov 13 |
| ValueAct Capital | 5.80% | 3,558,200 | ADDED (+8.5%) Q3 filed Nov 16 |
| Torray Investment Partners LLC | 3.08% | 573,623 | ADDED (+19.2%) Q3 filed Oct 30 |
| Lindsell Train | 2.33% | 667,780 | NEW Q3 filed Nov 2 |
| Markel Group | 1.01% | 1,451,800 | HELD Q3 filed Oct 30 |
| Dodge & Cox Funds | 0.39% | 8,060,515 | NEW Q3 filed Nov 13 |
| Ariel Investments | 0.39% | 424,241 | TRIMMED (-3.5%) Q3 filed Nov 13 |
| Aequim Alternative Investments | 0.05% | 32,000 | NEW Q3 filed Nov 12 |
| Oakmark Funds | 0.04% | 343,974 | TRIMMED (-7.0%) Q3 filed Nov 16 |
| Guinness Asset Management | 0.01% | 6,076 | TRIMMED (-15.0%) Q3 filed Nov 5 |
| Lone Pine Capital | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +2.1% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 1,301 of 8,857 filers |
| Long-only filers among them | 1,292 |
| Change vs 2026 Q1 | +7 net · 1,102 entered · 1,095 exited |
| Shares reported, all filers | 652,371,108 |
| Reported value, all filers | $51.9B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Investment Advice (SIC 6282) |
| Revenue · FY2025 | $19.5B |
| Net income · FY2025 | $2.4B |
| Total assets · FY2025 | $410.1B |
| Shares outstanding | 897,635,601 |
| Market cap (at latest close) | $84.1B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Aug 5, 2026.
| Shares short · Oct 15, 2026 | 17,138,513 |
| Share of shares outstanding | 1.91% |
| Days to cover | 2.64 |
Shares short at recent settlements — Jul 31, 2026: 14.2M · Aug 14, 2026: 12.5M · Aug 31, 2026: 13.7M · Sep 15, 2026: 13.6M · Sep 30, 2026: 13.8M · Oct 15, 2026: 17.1M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Aug 5, 2026.
| Shares failed to deliver · Oct 14, 2026 | 1,524 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | <0.1% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 497 · Oct 14, 2026: 2K.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Aug 5, 2026.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($1.1M).
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | HOLMES DANE E | Chief Administrative Officer | Sell | 10,000 | $108.58 | $1.1M | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | HOLMES DANE E | Officer | 10,000 | $1.1M | Sep 3, 2026 | SEC filing |
| Aug 7, 2025 | ROBERTS GEORGE R | See Remarks | 809,906 | $117.1M | Aug 7, 2025 | SEC filing |
| Jun 2, 2025 | ROBERTS GEORGE R | See Remarks | 1,190,094 | $145.0M | Jun 2, 2025 | SEC filing |
| Jun 2, 2025 | KRAVIS HENRY R | See Remarks | 1,150,469 | $140.2M | Jun 2, 2025 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Vanguard Capital Management | SC 13G | 50,647,147 | 5.7% | Mar 31, 2026 | SEC filing |
| Apr 27, 2026 | BlackRock, Inc. | SC 13G/A | 44,343,828 | 5.0% | Mar 31, 2026 | SEC filing |
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Jan 21, 2026 | BlackRock, Inc. | SC 13G | 44,890,451 | 5.0% | Dec 31, 2025 | SEC filing |
| Jul 17, 2025 | BlackRock, Inc. | SC 13G/A | 43,420,058 | 4.9% | Jun 30, 2025 | SEC filing |
| Feb 4, 2025 | BlackRock, Inc. | SC 13G | 46,989,395 | 5.3% | Dec 31, 2024 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Investment Advice (SIC 6282). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 17 Lobbying Disclosure Act filings named this company as client, 2025–2026; most common issues: Retirement (11), Financial Institutions/Investments/Securities (10), Taxation/Internal Revenue Code (9).
Federal contracts: $2.2M in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $0 |
| FY2022 | $7.0K |
| FY2023 | $746.8K |
| FY2024 | $954.7K |
| FY2025 | $341.5K |
| FY2026 | $170.8K |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| 75D30121F10977 | Department of Health and Human Services | $1.3M | May 17, 2021 |
| HHSD2002013572520007 | Department of Health and Human Services | $787.5K | Apr 1, 2017 |
| 75D30124C20135 | Department of Health and Human Services | $763.5K | Sep 27, 2024 |
| 75D30123C16444 | Department of Health and Human Services | $757.6K | Apr 26, 2023 |
| 75D30121P10420 | Department of Health and Human Services | $744.4K | Mar 1, 2021 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
This stock does not currently pass any tracked screen.
· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2026 Q1, ranked #11 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 14 | 50.0% | +3.3% | +2.1% | +1.2% |
| Share count tripled (3x) | 2 | 50.0% | +9.4% | +5.5% | +3.9% |
| Heavy exit — 3+ tracked funds sold out together | 2 | 100.0% | +10.8% | +7.1% | +3.7% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold KKR — ranked by lift, the co-holding pattern described in Methodology: Carlyle Group Inc. (CG) · AFFILIATED MANAGERS GROUP, INC. (AMG) · Blackstone Inc. (BX) · ROPER TECHNOLOGIES INC (ROP) · Arthur J. Gallagher & Co. (AJG) · Mondelez International, Inc. (MDLZ) · LOCKHEED MARTIN CORP (LMT) · STATE STREET CORP (STT).
| Filed | Items | Source |
|---|---|---|
| Nov 9, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Nov 4, 2026 | 7.01 Regulation FD Disclosure | SEC filing |
| Oct 26, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 5.07 Submission of Matters to a Vote of Security Holders · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Carlyle Group Inc. (CG) · Track Record: how the signals scored · Practice timing on KKR
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.